Your browser doesn't support javascript.
loading
Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial.
Meiser, Andreas; Volk, Thomas; Wallenborn, Jan; Guenther, Ulf; Becher, Tobias; Bracht, Hendrik; Schwarzkopf, Konrad; Knafelj, Rihard; Faltlhauser, Andreas; Thal, Serge C; Soukup, Jens; Kellner, Patrick; Drüner, Matthias; Vogelsang, Heike; Bellgardt, Martin; Sackey, Peter.
Afiliação
  • Meiser A; Department of Anaesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany. Electronic address: andreas.meiser@uks.eu.
  • Volk T; Department of Anaesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.
  • Wallenborn J; Department of Anesthesiology and Intensive Care Medicine, Helios Klinikum Aue, Aue, Germany.
  • Guenther U; University Clinic of Anaesthesiology, Intensive Care, Emergency Medicine, Pain Therapy, Klinikum Oldenburg, Oldenburg, Germany.
  • Becher T; Department of Anesthesiology and Intensive Care Medicine, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Bracht H; Department of Emergency Medicine, and Department of Anesthesiology and Intensive Care, University Hospital Ulm, Ulm, Germany.
  • Schwarzkopf K; Department of Anesthesia and Intensive Care, Klinikum Saarbrücken, Saarbrücken, Germany.
  • Knafelj R; University Medical Center Ljubljana, Ljubljana, Slovenia.
  • Faltlhauser A; Medical Department, Klinikum Weiden, Weiden, Germany.
  • Thal SC; Helios University Hospital Wuppertal, University of Witten-Herdecke, Department of Anesthesiology, Wuppertal, Germany; University Medical Center of the Johannes Gutenberg-University Mainz, Department of Anesthesiology, Mainz, Germany.
  • Soukup J; Department of Anaesthesiology, Intensive Care Medicine and Palliative Care Medicine, Carl-Thiem-Hospital, Cottbus, Germany.
  • Kellner P; Department of Anesthesiology and Intensive Care, University of Lübeck, University Medical Center Schleswig-Holstein, Lübeck, Germany.
  • Drüner M; Department of Anaesthesiology and Intensive Care Medicine, Emden Hospital, Emden, Germany.
  • Vogelsang H; St Josef-Hospital Bochum, Department of Anaesthesiology and Intensive Care Medicine, University Hospital of the Ruhr-University Bochum, Bochum, Germany.
  • Bellgardt M; St Josef-Hospital Bochum, Department of Anaesthesiology and Intensive Care Medicine, University Hospital of the Ruhr-University Bochum, Bochum, Germany.
  • Sackey P; Department of Physiology and Pharmacology, Unit of Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden.
Lancet Respir Med ; 9(11): 1231-1240, 2021 11.
Article em En | MEDLINE | ID: mdl-34454654
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propofol / Isoflurano / Anestésicos Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Respir Med Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propofol / Isoflurano / Anestésicos Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Respir Med Ano de publicação: 2021 Tipo de documento: Article